Przyklenk K, Ghafari G B, Eitzman D T, Kloner R A
Department of Internal Medicine, Detroit, Michigan.
J Am Coll Cardiol. 1989 Apr;13(5):1176-83. doi: 10.1016/0735-1097(89)90281-7.
Recent evidence suggests that postischemic contractile dysfunction of viable myocardium salvaged by reperfusion ("stunned myocardium") may be a consequence of abnormal calcium flux within the previously ischemic cells. Calcium channel blocking agents have been shown to enhance contractile function of stunned postischemic tissue, but it is not certain whether these improvements in function are due to the profound hemodynamic and vasodilator effects of these agents or to a direct effect on calcium flux within the stunned myocytes. Therefore, the effects of 1) high doses of nifedipine, given intravenously at 30 min after reperfusion, and 2) minute doses of nifedipine, infused directly into the coronary circulation at 30 min after reflow, were assessed and compared in anesthetized open chest dogs subjected to 15 min of transient coronary artery occlusion. As anticipated, intravenous nifedipine significantly reduced arterial pressure and increased regional myocardial blood flow. In addition, intravenous nifedipine restored systolic contractile function of the stunned, previously ischemic tissue to essentially normal preocclusion values: segment shortening averaged 102 +/- 8% versus 26 +/- 11% of baseline at 2 h after treatment in treated versus control dogs, respectively (p less than 0.003). Low dose intracoronary infusion of nifedipine did not alter hemodynamic variables or myocardial blood flow, but did improve segment shortening (90 +/- 9% versus 37 +/- 10% of preocclusion values at 1 h after treatment versus 25 min after reperfusion [that is, pretreatment], respectively; p less than 0.03). These data indicate that the calcium channel blocking agent nifedipine, given 30 min after reperfusion, enhances systolic contractile function of postischemic stunned myocardium.(ABSTRACT TRUNCATED AT 250 WORDS)
近期证据表明,再灌注挽救的存活心肌的缺血后收缩功能障碍(“心肌顿抑”)可能是先前缺血细胞内钙通量异常的结果。钙通道阻滞剂已被证明可增强缺血后顿抑组织的收缩功能,但尚不确定这些功能改善是由于这些药物的显著血流动力学和血管舒张作用,还是对顿抑心肌细胞内钙通量的直接作用。因此,在接受15分钟短暂冠状动脉闭塞的麻醉开胸犬中,评估并比较了1)再灌注后30分钟静脉注射高剂量硝苯地平,以及2)再灌注后30分钟直接注入冠状动脉循环的微量硝苯地平的效果。正如预期的那样,静脉注射硝苯地平显著降低动脉压并增加局部心肌血流量。此外,静脉注射硝苯地平使顿抑的先前缺血组织的收缩功能恢复到基本正常的闭塞前值:治疗组犬与对照组犬在治疗后2小时,节段缩短分别平均为基线的102±8%和26±11%(p<0.003)。低剂量冠状动脉内输注硝苯地平未改变血流动力学变量或心肌血流量,但确实改善了节段缩短(治疗后1小时分别为闭塞前值的90±9%和再灌注后25分钟[即预处理时]的37±